Asthma phenotypes in children and stratified pharmacological treatment regimens

References

• Koopman LP, Brunekreef B, De Jongste JC, et al. Definition of respiratory symptoms and disease in early childhood in large prospective birth cohort studies that predict the development of asthma. Pediatr Allergy Immunol. 2001;12(3):118–124.
   PubMed Web of Science ®Google Scholar
• Henderson J, Granell R, Heron J, et al. Associations of wheezing phenotypes in the first 6 years of life with atopy, lung function and airway responsiveness in mid-childhood. Thorax. 2008;63(11):974–980.
   PubMed Web of Science ®Google Scholar
• Spycher BD, Silverman M, Brooke AM, et al. Distinguishing phenotypes of childhood wheeze and cough using latent class analysis. Eur Respir J. 2008;31(5):974–981.
   PubMed Web of Science ®Google Scholar
• Campo P, Rodríguez F, Sánchez-García S, et al. Phenotypes and endotypes of uncontrolled severe asthma: new treatments. J Investig Allergol Clin Immunol. 2013;23(2):76-88; quiz 1 p. follow 88.
   PubMed Web of Science ®Google Scholar
• Cisneros Serrano C, Melero Moreno C, Almonacid Sánchez C, et al. Guidelines for severe uncontrolled asthma. Arch Bronconeumol. 2015;51(5):235–246.
   PubMed Web of Science ®Google Scholar
• Yoo Y. Phenotypes and endotypes of severe asthma in children. Korean J Pediatr. 2013;56(5):191–195.
   PubMedGoogle Scholar
• Lotvall J, Akdis CA, Bacharier LB, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127(2):355–360.
   PubMed Web of Science ®Google Scholar
• Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The group health medical associates. N Engl J Med. 1995;332(3):133–138.
   PubMed Web of Science ®Google Scholar
• Just J, Gouvis-Echraghi R, Couderc R, et al. Novel severe wheezy young children phenotypes: boys atopic multiple-trigger and girls nonatopic uncontrolled wheeze. J Allergy Clin Immunol. 2012;130(1):103–10 e8.
   PubMed Web of Science ®Google Scholar
• Weinmayr G, Keller F, Kleiner A, et al. Asthma phenotypes identified by latent class analysis in the ISAAC phase II Spain study. Clin Exp Allergy. 2013;43(2):223–232.
   PubMed Web of Science ®Google Scholar
• Howrylak JA, Fuhlbrigge AL, Strunk RC, et al. Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications. J Allergy Clin Immunol. 2014;133(5): 1289-300, 1300 e1-12.
   PubMed Web of Science ®Google Scholar
• Ong MS, Umetsu DT, Mandl KD. Consequences of antibiotics and infections in infancy: bugs, drugs, and wheezing. Ann Allergy Asthma Immunol. 2014;112(5):441–445 e1.
   PubMed Web of Science ®Google Scholar
• Garcia-Aymerich J, Benet M, Saeys Y, et al. Phenotyping asthma, rhinitis and eczema in MeDALL population-based birth cohorts: an allergic comorbidity cluster. Allergy. 2015;70(8):973–984.
   PubMed Web of Science ®Google Scholar
• Galobardes B, Granell R, Sterne J, et al. Childhood wheezing, asthma, allergy, atopy, and lung function: different socioeconomic patterns for different phenotypes. Am J Epidemiol. 2015;182(9):763–774.
   PubMed Web of Science ®Google Scholar
• Garden FL, Simpson JM, Mellis CM, et al. Change in the manifestations of asthma and asthma-related traits in childhood: a latent transition analysis. Eur Respir J. 2016;47(2):499–509.
   PubMed Web of Science ®Google Scholar
• Brand PL, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J. 2008;32(4):1096–1110.
   PubMed Web of Science ®Google Scholar
• Mallol J, García-Marcos L, Solé D, et al. International prevalence of recurrent wheezing during the first year of life: variability, treatment patterns and use of health resources. Thorax. 2010;65(11):1004–1009.
   PubMed Web of Science ®Google Scholar
• Ducharme FM, Tse SM, Chauhan B. Diagnosis, management, and prognosis of preschool wheeze. Lancet. 2014;383(9928):1593–1604.
   PubMed Web of Science ®Google Scholar
• Bacharier LB, Phillips BR, Bloomberg GR, et al. Severe intermittent wheezing in preschool children: a distinct phenotype. J Allergy Clin Immunol. 2007;119(3):604–610.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AM, Teague WG. Severe asthma in children: insights from the national heart, lung, and blood institute’s severe asthma research program. Pediatr Allergy Immunol Pulmonol. 2010;23(2):131–138.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AM, Gaston BM, Erzurum SC, et al. Features of severe asthma in school-age children: a topy and increased exhaled nitric oxide. J Allergy Clin Immunol. 2006;118(6):1218–1225.
   PubMed Web of Science ®Google Scholar
• Brand PL, Caudri D, Eber E, et al. Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J. 2014;43(4):1172–1177.
   PubMed Web of Science ®Google Scholar
• Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med. 2003;349(15):1414–1422.
   PubMed Web of Science ®Google Scholar
• Castro-Rodriguez JA. The Asthma Predictive Index: early diagnosis of asthma. Curr Opin Allergy Clin Immunol. 2011;11(3):157–161.
   PubMed Web of Science ®Google Scholar
• Tenero L, Piazza M, Piacentini G. Recurrent wheezing in children. Transl Pediatr. 2016;5(1):31–36.
   PubMed Web of Science ®Google Scholar
• Amin P, Levin L, Epstein T, et al. Optimum predictors of childhood asthma: persistent wheeze or the Asthma Predictive Index?. J Allergy Clin Immunol Pract. 2014;2(6):709–715.
   PubMed Web of Science ®Google Scholar
• Castro-Rodríguez JA, Holberg CJ, Wright AL, et al. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1403–1406.
   PubMed Web of Science ®Google Scholar
• Guilbert TW, Morgan WJ, Krawiec M, et al. The prevention of early asthma in kids study: design, rationale and methods for the childhood asthma research and education network. Control Clin Trials. 2004;25(3):286–310.
   PubMedGoogle Scholar
• Kurukulaaratchy RJ, Matthews S, Holgate ST, et al. Predicting persistent disease among children who wheeze during early life. Eur Respir J. 2003;22(5):767–771.
   PubMed Web of Science ®Google Scholar
• Devulapalli CS, Carlsen KCL, Håland G, et al. Severity of obstructive airways disease by age 2 years predicts asthma at 10 years of age. Thorax. 2008;63(1):8–13.
   PubMed Web of Science ®Google Scholar
• Caudri D, Wijga A, A Schipper CM, et al. Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age. J Allergy Clin Immunol. 2009;124(5): 903-10 e1-7.
   PubMed Web of Science ®Google Scholar
• Durrani S, Guilbert TW. Early treatment in preschool children: an evidence-based approach. Curr Opin Allergy Clin Immunol. 2015;15(2):175–183.
   PubMed Web of Science ®Google Scholar
• He XY, Simpson JL, Wang F. Inflammatory phenotypes in stable and acute childhood asthma. Paediatr Respir Rev. 2011;12(3):165–169.
   PubMed Web of Science ®Google Scholar
• Romanet-Manent S, Charpin D, Magnan A, et al. Allergic vs nonallergic asthma: what makes the difference?. Allergy. 2002;57(7):607–613.
   PubMed Web of Science ®Google Scholar
• Froidure A, Mouthuy J, Durham SR, et al. Asthma phenotypes and IgE responses. Eur Respir J. 2016;47(1):304–319.
   PubMed Web of Science ®Google Scholar
• Wenzel SE. Complex phenotypes in asthma: current definitions. Pulm Pharmacol Ther. 2013;26(6):710–715.
   PubMed Web of Science ®Google Scholar
• Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354(9178):541–545.
   PubMed Web of Science ®Google Scholar
• Morgan WJ, Stern DA, Sherrill DL, et al. Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. Am J Respir Crit Care Med. 2005;172(10):1253–1258.
   PubMed Web of Science ®Google Scholar
• Spycher BD, Kuehni CE. Asthma phenotypes in childhood: conceptual thoughts on stability and transition. Eur Respir J. 2016;47(2):362–365.
   PubMed Web of Science ®Google Scholar
• Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218–224.
   PubMed Web of Science ®Google Scholar
• Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181(4):315–323.
   PubMed Web of Science ®Google Scholar
• Siroux V, Garcia-Aymerich J. The investigation of asthma phenotypes. Curr Opin Allergy Clin Immunol. 2011;11(5):393–399.
   PubMed Web of Science ®Google Scholar
• De Andrade WC, Lasmar LMDLBF, Ricci CDAT, et al. Phenotypes of severe asthma among children and adolescents in Brazil: a prospective study. BMC Pulm Med. 2015;15:36.
   PubMed Web of Science ®Google Scholar
• Kupczyk M, Ten Brinke A, Sterk PJ, et al. Frequent exacerbators–a distinct phenotype of severe asthma. Clin Exp Allergy. 2014;44(2):212–221.
   PubMed Web of Science ®Google Scholar
• Ziora D, Sitek P, Machura E, et al. [Bronchial asthma in obesity–a distinct phenotype of asthma?]. Pneumonol Alergol Pol. 2012;80(5):454–462.
   PubMedGoogle Scholar
• Castro-Rodriguez JA. A new childhood asthma phenotype: obese with early menarche. Paediatr Respir Rev. 2016;18:85–89.
   PubMed Web of Science ®Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373.
   PubMed Web of Science ®Google Scholar
• Sullivan SD, Rasouliyan L, Russo PA, et al. Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma. Allergy. 2007;62(2):126–133.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AM, Baena-Cagnani CE, Bacharier LB. Severe asthma in childhood: recent advances in phenotyping and pathogenesis. Curr Opin Allergy Clin Immunol. 2012;12(2):193–201.
   PubMed Web of Science ®Google Scholar
• Fainardi V, Saglani S. The need to differentiate between adults and children when treating severe asthma. Expert Rev Respir Med. 2015;9(4):419–428.
   PubMed Web of Science ®Google Scholar
• Saglani S, Payne DN, Zhu J, et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med. 2007;176(9):858–864.
   PubMed Web of Science ®Google Scholar
• Bossley CJ, Saglani S, Kavanagh C, et al. Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma. Eur Respir J. 2009;34(5):1052–1059.
   PubMed Web of Science ®Google Scholar
• Yin SS, Liu H, Gao X. Elevated exhaled fractional exhaled nitric oxide (FeNO) is a clinical indicator in uncontrolled childhood asthma patients on inhaled corticosteroids (ICS). Int J Clin Pharmacol Ther. 2016. [Epub ahead of print]
   Web of Science ®Google Scholar
• Liu AH, Zeiger R, Sorkness C, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007;119(4):817–825.
   PubMed Web of Science ®Google Scholar
• Gaillard EA, McNamara PS, Murray CS, et al. Blood eosinophils as a marker of likely corticosteroid response in children with preschool wheeze: time for an eosinophil guided clinical trial?. Clin Exp Allergy. 2015;45(9):1384–1395.
   PubMed Web of Science ®Google Scholar
• Brisk R, Heaney LG. Asthma control and exacerbations: two different sides of the same coin. Curr Opin Pulm Med. 2016;22(1):32–37.
   PubMed Web of Science ®Google Scholar
• Liu AH. Biomarkers and childhood asthma: improving control today and tomorrow. Allergy Asthma Proc. 2005;26(4):249–254.
   PubMed Web of Science ®Google Scholar
• Wenzel SE. Severe asthma in adults. Exp Lung Res. 2005;31(Suppl 1):22.
   PubMedGoogle Scholar
• Baines KJ, Simpson JL, Wood LG, et al. Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes. J Allergy Clin Immunol. 2014;133(4):997–1007.
   PubMed Web of Science ®Google Scholar
• Park HW, Dahlin A, Tse S, et al. Genetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroids. J Allergy Clin Immunol. 2014;133(3):664–9 e5.
   PubMed Web of Science ®Google Scholar
• Wenzel SE, Balzar S, Ampleford E, et al. IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression. Am J Respir Crit Care Med. 2007;175(6):570–576.
   PubMed Web of Science ®Google Scholar
• Hawkins GA, Robinson MB, Hastie AT, et al. The IL6R variation asp(358)ala is a potential modifier of lung function in subjects with asthma. J Allergy Clin Immunol. 2012;130(2):510–5 e1.
   PubMed Web of Science ®Google Scholar
• Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2006;354(19):1985–1997.
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Hermansen MN, Loland L, et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med. 2006;354(19):1998–2005.
   PubMed Web of Science ®Google Scholar
• Murray CS, Woodcock A, Langley SJ, et al. Secondary prevention of asthma by the use of inhaled fluticasone propionate in wheezy infants (IFWIN): double-blind, randomised, controlled study. Lancet. 2006;368(9537):754–762.
   PubMed Web of Science ®Google Scholar
• Dekhuijzen PN, Lavorini F, Usmani OS. Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat((R)) or HandiHaler((R)). Patient Prefer Adherence. 2016;10:1561–1572.
   PubMed Web of Science ®Google Scholar
• Van Aalderen WM, Grigg J, Guilbert TW, et al. Small-particle inhaled corticosteroid as first-line or step-up controller therapy in childhood asthma. J Allergy Clin Immunol Pract. 2015;3(5):721–31 e16.
   PubMed Web of Science ®Google Scholar
• Manuyakorn W, Howarth PH, Holgate ST. Airway remodelling in asthma and novel therapy. Asian Pac J Allergy Immunol. 2013;31(1):3–10.
   PubMed Web of Science ®Google Scholar
• Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999;160(3):1001–1008.
   PubMed Web of Science ®Google Scholar
• Vijverberg SJ, Koenderman L, Koster ES, et al. Biomarkers of therapy responsiveness in asthma: pitfalls and promises. Clin Exp Allergy. 2011;41(5):615–629.
   PubMed Web of Science ®Google Scholar
• Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics. 2009;123(3):e519–25.
   PubMed Web of Science ®Google Scholar
• Brand P. New guidelines on recurrent wheeze in preschool children: implications for primary care. Prim Care Respir J. 2008;17(4):243–245.
   PubMedGoogle Scholar
• Papi A, Nicolini G, Baraldi E, et al. Regular vs prn nebulized treatment in wheeze preschool children. Allergy. 2009;64(10):1463–1471.
   PubMed Web of Science ®Google Scholar
• Stempel DA, Szefler SJ, Pedersen S, et al. Safety of adding salmeterol to fluticasone propionate in children with asthma. N Engl J Med. 2016;375(9):840–849.
   PubMed Web of Science ®Google Scholar
• Schatz M. National Asthma Education and Prevention Program guidelines: what is new?. Expert Rev Clin Immunol. 2008;4(6):673–685.
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Zielen S, Garcia-Garcia ML, et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med. 2005;171(4):315–322.
   PubMed Web of Science ®Google Scholar
• Busse WW, Lemanske RF Jr. Expert panel report 3: moving forward to improve asthma care. J Allergy Clin Immunol. 2007;120(5):1012–1014.
   PubMed Web of Science ®Google Scholar
• Urbano FL. Review of the NAEPP 2007 expert panel report (epr-3) on asthma diagnosis and treatment guidelines. J Manag Care Pharm. 2008;14(1):41–49.
   PubMed Web of Science ®Google Scholar
• Weiler JM, Anderson SD, Randolph C, et al. Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter. Ann Allergy Asthma Immunol. 2010;105(6 Suppl):S1–47.
   PubMedGoogle Scholar
• Bender BG, Annett RD, Iklé D, et al. Relationship between disease and psychological adaptation in children in the childhood asthma management program and their families. camp research group. Arch Pediatr Adolesc Med. 2000;154(7):706–713.
   PubMedGoogle Scholar
• Del Giacco SR, Firinu D, Bjermer L, et al. Exercise and asthma: an overview. Eur Clin Respir J. 2015;2:27984.
   PubMed Web of Science ®Google Scholar
• Del Giacco SR, Carlsen KH, Du Toit G. Allergy and sports in children. Pediatr Allergy Immunol. 2012;23(1):11–20.
   PubMed Web of Science ®Google Scholar
• Mendes FA, Almeida FM, Cukier A, et al. Effects of aerobic training on airway inflammation in asthmatic patients. Med Sci Sports Exerc. 2011;43(2):197–203.
   PubMed Web of Science ®Google Scholar
• Moreira A, Delgado L, Haahtela T, et al. Physical training does not increase allergic inflammation in asthmatic children. Eur Respir J. 2008;32(6):1570–1575.
   PubMed Web of Science ®Google Scholar
• Del Giacco SR, Scorcu M, Argiolas F, et al. Exercise training, lymphocyte subsets and their cytokines production: experience of an Italian professional football team and their impact on allergy. Biomed Res Int. 2014;2014:429248.
   PubMed Web of Science ®Google Scholar
• Covar RA, Spahn JD, Murphy JR, et al. Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med. 2004;170(3):234–241.
   PubMed Web of Science ®Google Scholar
• Macleod KA, Horsley AR, Bell NJ, et al. Ventilation heterogeneity in children with well controlled asthma with normal spirometry indicates residual airways disease. Thorax. 2009;64(1):33–37.
   PubMed Web of Science ®Google Scholar
• Adams NP, Bestall JC, Jones P, et al. Fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst Rev. 2008;4:CD003534.
   Google Scholar
• Hossny E, Fujimura T, Ota Y, et al. The use of inhaled corticosteroids in pediatric asthma: update. World Allergy Organ J. 2016;9:26.
   PubMed Web of Science ®Google Scholar
• Greenstone IR, Ni Chroinin MN, Masse V, et al. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database Syst Rev. 2005;4:CD005533.
   Google Scholar
• Lemanske RF Jr., Mauger DT, Sorkness CA, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med. 2010;362(11):975–985.
   PubMed Web of Science ®Google Scholar
• Brusselle GG, Vanderstichele C, Jordens P, et al. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax. 2013;68(4):322–329.
   PubMed Web of Science ®Google Scholar
• Xystrakis E, Kusumakar S, Boswell S, et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest. 2006;116(1):146–155.
   PubMed Web of Science ®Google Scholar
• Paul G, Brehm JM, Alcorn JF, et al. Vitamin D and asthma. Am J Respir Crit Care Med. 2012;185(2):124–132.
   PubMed Web of Science ®Google Scholar
• Gao JM, Cai F, Peng M, et al. Montelukast improves air trapping, not airway remodeling, in patients with moderate-to-severe asthma: a pilot study. Chin Med J (Engl). 2013;126(12):2229–2234.
   PubMed Web of Science ®Google Scholar
• Park JS, Jang AS, Park SW, et al. Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics. Allergy Asthma Immunol Res. 2010;2(1):48–54.
   PubMed Web of Science ®Google Scholar
• Knuffman JE, Sorkness CA, Lemanske RF, et al. Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma. J Allergy Clin Immunol. 2009;123(2):411–416.
   PubMed Web of Science ®Google Scholar
• Rabinovitch N, Mauger DT, Reisdorph N, et al. Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma. J Allergy Clin Immunol. 2014;133(2):350–356.
   PubMed Web of Science ®Google Scholar
• Normansell, R., S Walker, SJ Milan, et al. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev. 2014;1:CD003559.
   PubMed Web of Science ®Google Scholar
• Lafeuille MH, Dean J, Zhang J, et al. Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma. Ann Allergy Asthma Immunol. 2012;109(1):59–64.
   PubMed Web of Science ®Google Scholar
• Humbert M, Beasley R, Ayres J, et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy. 2005;60(3):309–316.
   PubMed Web of Science ®Google Scholar
• Flood-Page P, Menzies-Gow A, Phipps S, et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest. 2003;112(7):1029–1036.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Korn S, Howarth P, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380(9842):651–659.
   PubMed Web of Science ®Google Scholar
• Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365(12):1088–1098.
   PubMed Web of Science ®Google Scholar
• Berry MA, Hargadon B, Shelley M, et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med. 2006;354(7):697–708.
   PubMed Web of Science ®Google Scholar
• Wenzel SE, Barnes PJ, Bleecker ER, et al. A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med. 2009;179(7):549–558.
   PubMed Web of Science ®Google Scholar
• Aryan Z, Compalati E, Comapalati E, et al. Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications. Expert Rev Vaccines. 2013;12(6):639–659.
   PubMed Web of Science ®Google Scholar
• Senti G, Kundig TM. Intralymphatic immunotherapy. World Allergy Organ J. 2015;8(1):9.
   PubMed Web of Science ®Google Scholar
• Durham SR, Penagos M. Sublingual or subcutaneous immunotherapy for allergic rhinitis?. J Allergy Clin Immunol. 2016;137(2):339–349 e10.
   PubMed Web of Science ®Google Scholar